anonymous
Guest
anonymous
Guest
Nice try! Yes, 2DR has not lived up to expectations. However, we sell a portfolio of drugs that add up to over 4 billion in annual sales. Our entire company employs less that 350 people. The entire company!!! Marketing, government affairs, managed markets, sales and executives. Less than 350 people with annual sales of over 4 billion dollars. The injectable is coming and a prep indication in very short order. Will we have a downsizing? Possibly. But not at massive levels. Even then you will have early retirement packages offered to those over the age of 55. So relax chicken little.
Actually be very afraid- way too many of us selling/managing niche products. 3 years ago, in house projections were for this division to be greater than $6 billion by year end 2020 with this many employees, so in their mind we are over $2 Billion in the hole this year alone.